Skip to Content

Dorzolamide Ophthalmic Solution

Last Updated: October 9, 2018
Status: Current

Products Affected - Description
    • Dorzolamide ophthalmic solution, Akorn, 2%, 10 mL bottle, 1 count, NDC 50383-0232-10
    • Dorzolamide ophthalmic solution, Bausch Health (formerly Valeant), 2%, 10 mL bottle, 1 count, NDC 24208-0485-10
    • Dorzolamide ophthalmic solution, Teva, 2%, 10 mL bottle, 1 count, NDC 00093-7618-43
    • Dorzolamide ophthalmic solution, Teva, 2%, 10 mL bottle, 1 count, NDC 00591-2481-79
Reason for the Shortage
    • Akorn has dorzolamide ophthalmic solution on shortage due to manufacturing delays.
    • Merck did not provide a reason for the shortage.
    • Sandoz did not provide a reason for the shortage.
    • Teva discontinued dorzolamide ophthalmic solution in April 2018.
    • Bausch Health has dorzolamide ophthalmic solution on shortage due to manufacturing delays.
Available Products
    • Trusopt ophthalmic solution, Merck, 2%, 10 mL Ocumeter Plus bottle, 1 count, NDC 00006-3519-36
    • Dorzolamide ophthalmic solution, Sandoz, 2%, 10 mL bottle, 1 count, NDC 61314-0019-10

Estimated Resupply Dates

    • Akorn has dorzolamide 2% ophthalmic solution on allocation.
    • Bausch Health has dorzolamide 2% ophthalmic solution on back order and the company estimates a release date in late-November 2018.

Updated

Updated October 9, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created October 30, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide